Molecular Pathology in Drug Development

Molecular pathology deals with tools and techniques that can significantly improve the drug discovery and development methods which help to make the possibilities of personalized medicine a reality. Molecular Pathology in drug discovery and development offers an incomparable guide to this leading-edge discipline and its applications to pharmaceutical science. With assistances from foremost illuminations in drug discovery, drug development, and molecular pathology, this field compromises the methods that are applied to the progression of drug discovery and development. The effectual and operative improvement of new targeted drugs will involve more comprehensive molecular arrangements of histologically homogeneous diseases that show heterogeneous clinical outcomes, which can be gained using molecular techniques in drug development.

  • Molecular pathology in oncology target and drug discovery
  • Molecular pathology and transcriptional profiling in early drug development
  • Molecular pathology in nonclinical safety assessment
  • Molecular pathology in development of antibacterial drugs

Related Conference of Molecular Pathology in Drug Development

April 25-26, 2024

22nd European Pathology Congress

London, UK
August 21-22, 2024

4th World Pathology Conference

Amsterdam, Netherlands
September 23-24, 2024

22nd Annual Pathology Congress

Dubai, UAE

Molecular Pathology in Drug Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in